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The nonlinear trimodal regression analysis (NTRA) method based on radiodensitometric CT 
distributions was recently developed and assessed for the quantification of lower extremity function 
and nutritional parameters in aging subjects. However, the use of the NTRA method for building 
predictive models of cardiovascular health was not explored; in this regard, the present study reports 
the use of NTRA parameters for classifying elderly subjects with coronary heart disease (CHD), 
cardiovascular disease (CVD), and chronic heart failure (CHF) using multivariate logistic regression 
and three tree-based machine learning (ML) algorithms. Results from each model were assembled as 
a typology of four classification metrics: total classification score, classification by tissue type, tissue-
based feature importance, and classification by age. The predictive utility of this method was modelled 
using CHF incidence data. ML models employing the random forests algorithm yielded the highest 
classification performance for all analyses, and overall classification scores for all three conditions 
were excellent: CHD (AUCROC: 0.936); CVD (AUCROC: 0.914); CHF (AUCROC: 0.994). Longitudinal 
assessment for modelling the prediction of CHF incidence was likewise robust (AUCROC: 0.993). The 
present work introduces a substantial step forward in the construction of non-invasive, standardizable 
tools for associating adipose, loose connective, and lean tissue changes with cardiovascular health 
outcomes in elderly individuals.
The progressive degeneration of skeletal muscle is consistently identified as an independent risk factor for sig-
nificant morbidity, disability, and mortality in aging individuals1–7. Defined as sarcopenia, recent literature has 
interrogated its mediating and moderating roles in a wide range of adverse health outcomes, including its role in 
the etiology of cardiovascular pathophysiology. Catabolic inflammatory cytokine production and characteristic 
adiposity from the progression of sarcopenia have been linked with the onset of diabetes8, hypertension9, and 
dyslipidemia10 – all of which are well-established risk factors for coronary heart disease (CHD)11 and all-type 
cardiovascular disease (CVD)12–15. Chronic heart failure (CHF) patients frequently develop cardiac cachexia, a 
similar muscle wasting condition whose advanced stage has been implicated as an accelerated analogue of sarco-
penic muscle degeneration16. Indeed, the progression of sarcopenia in older CHF patients may be considerably 
entangled with embedded cachexic effects16,17. While literature cites the associations and potential causal mecha-
nisms between cardiovascular pathophysiology and downstream changes in skeletal muscle form and function18, 
validating standardized predictive models for these conditions remains debated. Furthermore, incorporating 
more nuanced quantitative methods for the non-invasive prediction of these events remains a priority in litera-
ture. Identifying such a methodology would further establish the generalizability of skeletal muscle research to 
the early detection of cardiovascular pathophysiology and facilitate the identification of compensatory targets for 
clinical intervention.
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The concomitant loss of muscle mass and increase in adipose tissue in aging individuals suggest the use 
of quantitative imaging techniques, such as X-ray computed tomography (CT) or magnetic resonance imag-
ing (MRI) to characterize overall changes in skeletal muscle19–21. Indeed, another defining characteristic of 
aging is the loss of muscle strength from both the reduction of dense contractile myofibers and the infiltration 
of non-contractile adipose tissue - a phenomenon known as myosteatosis22. These changes altogether present 
a reduction in muscle ‘quality’, which has been cited as a significant causal mechanism in the loss of muscle 
function - particularly when in conjunction with reduced muscle mass13,14,23. CT imaging has shown particu-
lar utility in quantifying these changes20,21. This is often performed via the use of radiodensitometric absorp-
tion values, measured in Hounsfield units (HU). Here, changes in segmented cross-sectional areas have been 
used to illustrate changes in volume24–30, and changes in average HU values have been used to illustrate changes 
in muscle quality31,32. We have recently shown the utility of modelling entire radiodensitometric distributions 
from CT cross-sections of the mid-thigh, highlighting the novel nonlinear trimodal regression analysis (NTRA) 
method33,34. Indeed, soft tissue HU distributions associated with cross sections from the mid-thigh can be char-
acterized by tissue types: fat, loose connective, and lean muscle (Fig. 1). These sub-distributions are Gaussian in 
form and can be defined by amplitude, location, width, and skewness parameters. These parameters establish 
a unique 11-term soft tissue profile for each individual that can be defined using NTRA analysis for whole HU 
distributions32. In developing and using these profiles, we have demonstrated the predictive value of these param-
eters with functional biometrics, as well as biochemical and nutritional data from healthy aging volunteers in the 
longitudinal AGES-Reykjavík study. This large-scale population research study (n = 3,157) was designed to exam-
ine risk factors and disease associated with aging, including genetic susceptibility and environmental interactions.
In the present study, we compare the integration of these 11 NTRA parameters to classify elderly at risk for 
CHD, CVD, and CHF using multivariate logistic regression modelling and three different tree-based ML algo-
rithms: random forests (RF), ADA-Boost (ADA-B), and gradient boosting (GB). These algorithms were applied, 
using regression, by Recenti et al.35 on the AGES database with the NTRA parameters to predict Body Mass Index 
(BMI). Figure 1 depicts this study workflow. Results from each ML model were assembled over a typology of four 
predictive comparisons: total classification score, classification by tissue type, tissue-based feature importance, 
classification by age. Further model validation was compared for each ML model using longitudinal CHF data. 
Results from this investigation highlight the substantial capacity of NTRA-based ML modelling to predict all 
three cardiovascular health outcomes; these findings are most evidenced by the high classification scores of RF 
models with CHF – findings which are further validated by the robust predictive performance of CHF incidence 
from longitudinal data. The present study altogether serves as a substantial step forward in the construction of 
reproducible tools for predicting cardiovascular health in elderly individuals.
Results
Descriptive AGES-Reykjavik statistics and NTRA parameters. Prior to the construction of logistic 
regression and ML models, descriptive statistics and mean NTRA parameters were assembled from the AGES-I 
and AGES-II databases. Table 1 contains a summary of these values. These NTRA parameters describe four fun-
damental features of each individual’s HU distribution: amplitude, width, location and skewness. The amplitude 
and width terms generally describe the summed area of each tissue type. The location parameter indicates mean 
tissue radiodensity, while skewness reflects the geometrical symmetry of the muscle and fat Gaussian distribu-
tions (See Fig. 1). As shown, from the total sample size of n = 3,157 subjects who were present for both studies, 
Figure 1. Workflow of the present study with nonlinear trimodal regression analysis parameters Gaussian 
distribution: from a mid-thigh CT scan, 11 radiodensitometric distributions parameter are extracted and used 
as features for assessing cardiovascular risks through three tree-based algorithms.
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there were no changes in subsamples for CHD or all-type CVD (n = 628 and 753, respectively). However, the 
number of subjects with CHF increased from n = 59 to 183 in the five years between these datasets. Mean NTRA 
parameters were similar between subjects presenting with cardiovascular pathophysiology, but amplitude (N), 
location (μ), and width (σ) parameters differed somewhat for individuals with no condition.
Logistic regression models. As described, three multivariate logistic regression models were generated for 
CHD, CVD, and CHF binary indicator variables using each of the 11 NTRA parameters as independent variables, 
and age and sex as hypothesized confounders. No discernable NTRA nonlinearity was observed from NTRA logit 
scatter plots, and deviance residual diagnostic plots yielded negligible heteroscedasticity and no high-leverage 
outliers (see Appendix A for logit plots, predicted probability curves, and deviance residual diagnostic plots). 
Results from each logistic regression model are assembled in Table 2.
As evident in Table 2, the use of the 11 NTRA parameters in each logistic regression model yielded high 
overall model significance to each cardiac pathophysiology (p < 0.001), and both age and sex were indeed highly 
significant confounders (p < 0.001). However, individual-level significance from each NTRA parameter varied 
in specificity to each condition. Interestingly, the CHD and CVD models yielded analogously-significant NTRA 
parameters: fat amplitude and connective tissue amplitude, location, and width; contrastingly, nearly every NTRA 
parameter was significant in predicting the CHF outcome, with the exceptions of connective tissue location and 
both fat and muscle skewness. This indicates that the prediction of CHD and CVD using NTRA logistic regres-
sion may only require four parameters from the NTRA profile, with the connective tissue feature being a domi-
nant independent variablesin this regard. Finally, the results associated to CHF indicates the importance of eight 
of the 11 NTRA parameters, with relatively shared importance from fat, muscle and connective tissue.
As sex was a significant confounder in our logistic regression model, mean NTRA parameters were compared 
between male and female volunteers for each cardiac pathophysiology. Results from this comparison are shown 
in Table 3. From this assessment, there were few significant differences between individual NTRA parameters 
according to sex and condition, with the exception of muscle skewness, where female subjects presenting all three 
conditions had significantly higher skewness values than those without the condition. Figure 2 illustrates the 
mean HU distributions male and female subjects with and without CHF, as an example condition (see Appendix 
B for CHD and CVD distributions).
As is evident in Fig. 2, while there are very few visual differences between HU distributions for subjects with 
or without CHF, but clear differences between male and female distribution curves. Here, the fat distribution is 
much more pronounced in female subjects, whereas the muscle distribution is more pronounced in male sub-
jects. Likewise, the central connective tissue distribution is centered near 0 HU for males, but around −40 HU 
for females.







Condition CHD CVD CHF
No 
Condition
Sample size (n)* 628 753 59 2394 Sample size (n)* 628 753 183 2322
Age: Mean (SD) 75.5 (4.7) 75.6 (4.8) 76.6 (5.3) 74.6 (4.8) Age: Mean (SD) 80.7 (4.7) 80.8 (4.8) 82.3 (5.3) 79.7 (4.8)
Sex (Male) 419 464 34 859 Sex (Male) 419 464 96 831
Sex (Female) 209 289 25 1535 Sex (Female) 209 289 87 1491
Mean NTRA (SD) Mean NTRA (SD)





N 51.5 (28.5) 53.5 (29.1) 54.8 (25.8) 64.6 (33.9)
Fat
Amplitude: 
N 52.7 (28.9) 54.2 (29.3) 58.8 (29.6) 64.6 (33.9)
Location: μ −118.0 (3.8) −117.9 (3.7) −116.6 (4.2) −117.8 (3.2) Location: μ −117.0 (5.3) −116.8 (5.9) −115.9 (4.5) −117.3 (4.2)
Width: σ 9.6 (6.8) 9.2 (6.5) 8.4 (4.8) 7.9 (5.7) Width: σ 9.1 (6.2) 8.9 (6.0) 8.5 (5.2) 7.9 (5.6)
Skewness: α −2.8 (2.2) −2.7 (2.2) −2.3 (1.4) −2.4 (2.0) Skewness: α −2.7 (2.0) −2.6 (2.0) −2.7 (1.8) −2.4 (1.9)
Connective
Amplitude: 
N 43.6 (9.0) 43.2 (9.0) 43.2 (10.4) 41.2 (8.2)
Connective
Amplitude: 
N 43.9 (9.7) 43.4 (9.6) 42.2 (10.2) 41.4 (9.0)
Location: μ −14.5 (28.2) −16.7 (28.3) −21.0 (28.2) −26.3 (28.3) Location: μ −17.7 (27.3) −19.2 (27.6) −27.7 (30.7) −27.6 (28.0)
Width: σ 24.3 (6.0) 24.5 (5.9) 24.9 (6.1) 25.3 (5.7) Width: σ 23.9 (5.5) 24.0 (5.6) 22.2 (5.3) 24.9 (5.5)
Muscle
Amplitude: 
N 82.4 (18.9) 81.2 (18.6) 78.3 (19.7) 77.1 (17.6)
Muscle
Amplitude: 
N 76.3 (18.4) 75.0 (18.2) 69.8 (17.7) 72.0 (17.1)
Location: μ 61.5 (2.7) 61.4 (2.7) 61.0 (2.9) 61.5 (2.6) Location: μ 60.9 (2.9) 60.7 (3.0) 59.5 (3.2) 61.0 (2.8)
Width: σ 8.5 (2.3) 8.6 (2.2) 8.9 (2.1) 8.6 (2.1) Width: σ 9.1 (2.5) 9.1 (2.5) 10.1 (3.4) 9.1 (2.6)
Skewness: α 2.9 (0.9) 2.9 (0.9) 3.0 (0.7) 2.8 (0.7) Skewness: α 2.9 (0.8) 2.9 (0.8) 3.2 (0.9) 2.9 (0.8)
Table 1. Summary statistics and nonlinear trimodal regression analysis parameters with relative standard 
deviation (SD) from AGES-I and AGES-II subjects by cardiac pathophysiology (coronary heart disease (CHD), 
cardiovascular disease (CVD), chronic heart failure (CHF), and no condition). Note: *From the total sample 
size of n = 3,157 subjects that participated in both the AGES-I and AGES-II studies, 585 individuals presented 
with more than one cardiac pathophysiology.
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ML models. Total classification scores: K-fold cross-validation and NTRA by k = 12. Prior to the generation 
of ML models, the smote technique was applied for all cardiac conditions to obtain a balanced dataset with an 
equal distribution of sick and healthy people. In this phase, the 11 NTRA parameters were employed to make 
the predictions with GB, RF and ADA-B. K-fold cross-validation was employed three times (k = 8,10, and 12) to 
compute the pathophysiology predictions; here, the 12-fold cross-validation was empirically found to be the best 
option for predicting all three conditions (see Appendix C for k = 8 and k = 10 results). The results from k = 12 
analyses are summarized in Table 4 and the respective ROC curves are shown in Fig. 3.
Regarding the ML analyses, CHF was classified with the highest overall scores; specifically, the RF method 
yielded the best results, evidenced by an accuracy of 95.9%, an exceptionally high AUCROC of 0.994, and all 
additional scores above 95.0%. Nevertheless, ADA-B likewise surpassed 90.0% accuracy and obtained a high 
AUCROC (0.987). Concerning the CHD condition, ADA-B again obtained the second highest accuracy among 
all pathophysiologies, and RF was again the best algorithm (85.0% in accuracy and AUCROC of 0.936). CVD was 
likewise accurately predicted, although the condition yielded the weakest overall results among the three, with a 
highest achieved predictive accuracy of 82.1% obtained from the RF method and AUCROC of 0.914.
NTRA-based classification by tissue type. In regarding the elaborations presented by logistic regression, ML 
analyses were further employed with features grouped by the three tissue types defined by their inherent NTRA 
parameters, as described: N, μ, σ, and α for fat and lean muscle, and N, μ, and σ for loose connective tissue. 
Table 5 details the evaluation metrics computed per ML algorithm in this regard, defined by each tissue type and 
cardiac pathophysiology.
When predicting cardiac pathophysiology from NTRA defined tissue type (Table 5), the best results were 
again obtained from RF models; CHF was predicted with mean accuracies of 88.4%, 89.6% and 86.6% for fat, 
muscle, and connective tissue, respectively. Fat’s features, in general, yielded the best overall predictive value for 
CHF. In comparison, CHD was predicted with an accuracy of 79.6% by fat and muscle, and 78.4% by connective 
tissue; all tissues yielded nearly identical overall predictive results. In predicting CVD, the tissues, commensurate 
with the previous ML results, obtained the lowest overall scores (under 80.0%). The highest model performances, 
in accordance with AUCROC, were achieved with the prediction of CHF, wherein all models surpassed the value 
of 0.9.
Tissue-based feature importance. Next, feature importance was computed and grouped again by tissue type 
defined by NTRA parameters, allowing for the comparison of the respective contributions from fat, muscle, and 
connective tissue NTRA values towards the accuracy of pathophysiology prediction. These tissue contributions 
are detailed in Fig. 4, alongside an example of a segmented false-color CT cross-section that illustrates the mor-
phology of each NTRA tissue type.
NTRA-based classification by age. As logistic regression models implicated age and sex as strongly significant 
confounders for prediction of all three cardiac conditions, we additionally sought to illustrate whether the excel-
lent classification scores identified in initial ML analyses held with respect to age, indicating their relative depend-
encies. From the original database, individuals were classified into three subgroups according to their age: 66–75, 
76–84, and 85–98 years old. Results from these analyses are shown in Table 6.
For CVD, the maximum classification accuracy and AUCROC were 82.1% and 0.914; splitting into three 
groups, RF kept on being the best algorithm and showed an accuracy between 78.0% and 85.4%, and an AUCROC 
between 0.875 and 0.937. Concerning CHD, the best accuracy and AUCROC were 85.0% and 0.937, respec-
tively; subgrouping by age, RF obtained an accuracy above 82.0% for all subgroups and an AUCROC above 0.9 
for each group. Finally, CHF showed again the best results with an accuracy range between 88.6% and 95.6% 
and AUCROC between 0.962 and 0.994 through RF. Despite subgrouping by age, results were still excellent, 
Tissue: NTRA:
Outcome variable OR (95% CI):
CHD*** CVD*** CHF***
Fat
Amplitude: N 0.987*** (0.984–0.991) 0.989*** (0.986–0.993) 0.986*** (0.979–0.993)
Location: μ 0.999 (0.983–1.01) 1.01 (0.992–1.02) 1.05*** (1.03–1.08)
Width: σ 0.993 (0.966–1.02) 0.984 (0.958–1.011) 0.927* (0.868–0.981)
Skewness: α 1.03 (0.966–1.11) 1.01 (0.950–1.08) 0.898 (0.788–1.02)
Connective
Amplitude: N 1.03*** (1.02–1.04) 1.03*** (1.02–1.04) 1.04*** (1.02–1.06)
Location: μ 1.01* (1.00–1.01) 1.01* (1.00–1.01) 0.999 (0.988–1.01)
Width: σ 0.970** (0.952–0.988) 0.972** (0.955–0.989) 0.935*** (0.900–0.971)
Muscle
Amplitude: N 1.00 (0.998–1.01) 1.00 (0.996–1.00) 0.982*** (0.973–0.990)
Location: μ 0.997 (0.971–1.02) 0.986 (0.962–1.01) 0.937** (0.895–0.981)
Width: σ 1.05 (0.997–1.11) 1.05 (0.998–1.10) 1.11* (1.02–1.19)
Skewness: α 1.00 (0.892–1.13) 1.02 (0.915–1.14) 0.953 (0.791–1.14)
Table 2. Multivariate logistic regression models for coronary heart disease (CHD), cardiovascular disease 
(CVD) and chronic heart failure (CHF) using soft tissue nonlinear trimodal regression analysis parameters 
from CT images of the mid-thigh. Notes: For each model, sex and age yielded strong significance (p < 0.001) as 
corrected confounders. *p < 0.05; **p < 0.01; ***p < 0.001.
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presenting an accuracy range of 92.6% to 97.9% and AUCROC between 0.981 and 0.998. These results confirm 
that ML classification is accurate, independent from age as a confounder, and considering the operation of these 
algorithms, it is further reasonable to assume an analogous classification independence from sex in prediction.
NTRA-based longitudinal assessment. In order to validate the ML prediction results, a cross sectional dataset 
obtained between AGES-I and AGES-II was used; here, only CHF was possible to assess due to no change in the 
number of individuals who received a CVD or CHD diagnosis between the two study timepoints.
To test the predictive potential of our ML models against the diagnosis of CHF, an incidence index was 
defined; here, the null condition ‘0’ was assigned as a control to subjects without CHF in either AGES-I or 
AGES-II, whereas ‘1’ was assigned to those without CHF in AGES-I but with the condition in AGES-II. This 
method thereby removed all individuals presenting CHF at both timepoints. Table 7 illustrates the results from 










μ Width: σ Skewness: α
Amplitude: 
N Location: μ Width: σ
CHD
MaleY 838 38.3 (13.2) −117.7 (5.3) 11.0 (7.4) −3.1 (2.4) 86.2 (17.7) 61.4 (2.8) 8.3 (2.0) 2.8 (0.8) 45.8 (9.6) −2.8 (20.5) 23.5 (6.1)
MaleN 1790 37.9 (15.1) −117.9 (4.8) 11.5 (7.9) −3.3 (2.9) 86.2 (18.1) 61.5 (2.8) 8.1 (2.0) 2.7 (0.7) 44.5 (9.2) −1.7 (21.3) 23.3 (6.3)
FemaleY 418 79.7 (31.3) −117.1 (2.8) 5.9 (1.2) −2.0 (0.7) 65.5 (12.5) 60.7 (2.8) 9.8 (2.8) 3.2 (0.9)*** 39.7 (7.5) −42.6 (20.5) 25.2 (4.8)
FemaleN 3206 79.1 (32.4) −117.2 (3.3) 5.9 (1.9) −1.9 (0.9) 67.7 (13.0) 61.0 (2.8) 9.4 (2.5) 3.0 (0.7) 39.4 (7.7) −41.3 (20.5) 26.0 (5.0)
CVD
MaleY 928 38.4 (13.2) −117.5 (5.8) 11.0 (7.3) −3.1 (2.5) 85.8 (17.8) 61.4 (2.9) 8.3 (2.0) 2.8 (0.8) 45.6 (9.5) −3.0 (20.6) 23.5 (6.2)
MaleN 1700 38.5 (15.2) −118.0 (4.4) 11.5 (8.0) −3.3 (2.9) 86.5 (18.1) 61.5 (2.7) 8.1 (2.0) 2.7 (0.7) 44.6 (9.2) −1.6 (21.3) 23.3 (6.3)
FemaleY 578 78.7 (30.7) −117.1 (3.0) 5.9 (1.3) −2.0 (0.7) 65.7 (12.2) 60.6 (2.8) 9.8 (2.7) 3.1 (0.8)*** 39.6 (7.7) −42.0 (20.5) 25.4 (4.8)
FemaleN 3046 79.3 (32.6) −117.2 (3.3) 5.9 (1.9) −1.9 (0.9) 67.7 (13.1) 61.0 (2.8) 9.4 (2.5) 3.0 (0.7) 39.4 (7.7) −41.4 (20.5) 26.0 (5.0)
CHF
MaleY 130 41.3 (14.9) −116.0 (5.4) 10.5 (6.1) −2.9 (2.1) 79.6 (19.0) 59.7 (3.1) 8.9 (2.3) 2.9 (0.7)* 45.7 (10.4) −7.5 (21.5) 22.9 (5.7)
MaleN 2509 38.3 (14.5) −117.9 (4.9) 11.3 (7.8) −3.2 (2.8) 86.6 (17.8) 61.6 (2.7) 8.1 (2.0) 2.7 (0.8) 44.9 (9.3) −1.8 (21.0) 23.4 (6.2)
FemaleY 112 77.0 (29.1) −116.1 (3.0) 6.1 (1.7) −2.2 (1.1) 62.8 (13.3) 60.1 (3.1) 10.9 (3.7) 3.4 (1.0)** 38.7 (8.6) −47.6 (23.9) 22.8 (5.6)
FemaleN 3532 79.2 (32.3) −117.3 (3.2) 5.9 (1.8) −1.9 (0.8) 67.6 (13.0) 61.0 (2.7) 9.4 (2.5) 3.0 (0.8) 39.4 (7.7) −41.3 (20.4) 26.0 (4.9)
Table 3. Mean nonlinear trimodal regression analysis parameters from AGES-I and AGES-II subjects by sex 
and cardiac pathophysiology. The following convention for the p-value was employed: *p < 0.05; **p < 0.01; 
***p < 0.001.






[%] Sensitivity [%] Specificity [%]
Recall 
[%] Precision [%] AUCROC
CHD
GB 75.9 77.7 70.0 81.7 70.0 79.3 0.864
RF 85.0 87.4 81.7 88.4 81.7 87.6 0.936
ADA-B 79.5 82.2 74.9 84.1 74.9 82.4 0.873
CVD
GB 73.1 75.7 67.1 79.1 67.1 76.2 0.834
RF 82.1 83.9 78.8 85.5 78.8 84.5 0.914
ADA-B 70.2 77.0 63.3 77.2 63.3 73.5 0.766
CHF
GB 88.6 90.3 85.0 92.1 85.0 91.5 0.962
RF 95.9 96.5 95.0 96.9 95.0 96.8 0.994
ADA-B 94.0 95.4 92.1 95.8 92.1 95.7 0.987
Table 4. The 11 nonlinear trimodal regression analysis parameters were used to assess cardiovascular risks 
through machine learning algorithms. The evaluation metrics by cardiac pathophysiology were computed.
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As shown in Table 7, the RF method again yielded the best predictive accuracy (95.2%) and AUCROC (0.993) 
for the prediction of CHF incidence. In contrast, ADA-B was analogously second-best in predictive accuracy 
(94.3%), and GB was the least accurate of the three (88.3%). Nonetheless, each ML algorithm surpassed an 
AUCROC value of 0.95, as well as specificity and precision values greater than 90.0%.
Discussion
Deleterious changes in skeletal muscle in patients with poor cardiovascular health outcomes have been discussed 
in literature. Patients with CHF have been shown to develop significant ultrastructural abnormalities in their 
skeletal muscle, suggesting poor muscle oxidative capacity as reflected by decreased exercise capacity36,37. Indeed, 
abnormal skeletal muscle function, increased thigh intermuscular fat, and reduced exercise capacity have been 
Figure 3. ROC curves for coronary heart disease (CHD), cardiovascular disease (CVD) and chronic heart 
failure (CHF) classification with K-fold cross-validation and nonlinear trimodal regression analysis by k = 12.
Tissue Algor. Acc. Mean [%] Acc. Max [%] Sens. [%] Spec. [%] Recall [%] Precision [%] AUCROC
CHD
Fat
GB 73.8 75.2 69.6 78.0 69.6 75.9 0.828
RF 79.6 82.2 76.1 83.1 76.1 81.8 0.884
ADA-B 63.9 65.0 52.0 75.8 52.0 68.3 0.674
Connective
GB 74.3 77.5 70.0 78.6 70.0 76.6 0.824
RF 78.4 80.2 74.4 82.4 74.4 80.9 0.876
ADA-B 63.3 65.4 56.3 70.5 56.2 65.6 0.680
Muscle
GB 74.0 76.4 69.0 78.9 69.0 76.6 0.824
RF 79.6 82.2 76.6 82.6 76.6 81.4 0.885
ADA-B 63.6 66 63.3 63.9 63.3 63.7 0.673
CVD
Fat
GB 71.0 73.3 66.1 75.8 66.1 73.2 0.794
RF 76.8 78.1 73.8 79.8 73.8 78.5 0.855
ADA-B 61.5 64.1 50.8 72.2 50.8 64.7 0.645
Connective
GB 71.3 74.3 66.0 76.7 66.0 73.9 0.792
RF 76.1 78.5 71.8 80.3 71.8 78.5 0.846
ADA-B 61.6 63.4 58.3 64.8 58.3 62.4 0.654
Muscle
GB 70.2 72.8 65.0 75.5 65.0 72.6 0.788
RF 76.8 78.9 73.7 79.9 73.7 78.6 0.854
ADA-B 60.7 63.8 56.8 64.6 56.8 61.6 0.644
CHF
Fat
GB 83.0 85.0 80.2 85.9 80.2 85.0 0.918
RF 88.4 90.0 87.3 89.4 87.3 89.2 0.956
ADA-B 85.6 88.7 83.3 88.0 83.3 87.4 0.927
Connective
GB 82.4 83.8 80.2 84.6 80.2 83.9 0.907
RF 86.6 87.6 86.5 86.7 86.5 86.7 0.939
ADA-B 82.9 85.2 80.9 84.9 80.9 84.3 0.905
Muscle
GB 84.0 86.5 81.4 86.6 81.4 85.8 0.922
RF 89.6 91.2 89.4 89.8 89.4 89.8 0.96
ADA-B 87.4 89.1 85.7 89.2 85.7 88.8 0.943
Table 5. The 11 nonlinear trimodal regression analysis parameters grouped by tissue type (fat, connective and 
muscle) were used to assess cardiovascular risks through machine learning algorithms and evaluation metrics 
were computed.
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cited as primary chronic symptoms in heart failure patients with preserved ejection fraction (HFpEF)38. However, 
literature on the use of ML-modelling for the prediction of these conditions remains scarce, despite recent sys-
tematic review evidence that highlights its promising utility in datamining and classifying health outcomes39,40.
At the time of this work, only one study could be found that reports using ML-modelling of CT images to 
classify individuals according to cardiovascular health outcomes. In this study, coronary CT angiography images 
were combined with ML-modelling to develop an artificial intelligence-based imaging biomarker to predict 
myocardial infarction in healthy subjects41. However, the use of CT images of skeletal muscle for classifying 
cardiovascular health outcomes remains unreported. Furthermore, the methodological heterogeneity between 
ML-based clinical studies is generally high, as predictive parameters or ML methods remain largely study-specific 
and unstandardized. As such, the present work aimed to explore ML-modelling techniques to classify individuals 
diagnosed with CHD, CVD, and CHF using CT-based NTRA parameters as a quantitative construct for skeletal 
muscle health.
Summary of main findings. From our multivariate logistic regression models, several key trends emerged 
when comparing the odds ratios for each significant NTRA parameter. Notably, both fat amplitude and con-
nective tissue width were significantly and inversely-related to all three outcome conditions; this suggests that 
an increase in fat tissue, concomitant with a wider connective tissue distribution, may be significant protective 
factors against cardiovascular pathophysiology. However, an increase in fat amplitude as a protective factor is 
somewhat counterintuitive, as increased skeletal muscle adiposity has been readily linked with poor cardiovas-
cular health outcomes42. Nevertheless, these models indicate that connective tissue amplitude is significantly and 
directly related to all three outcome conditions, as an accumulation of pixels at this center radiodensitometric 
distribution was significantly associated with the probability of CHD, CVD, and CHF. Finally, as each model was 
generated from the same series of NTRA parameters, it is further useful to directly compare Akaike information 
criteria (AIC) to resolve any differences in trade-off between model fit and complexity. AIC values for the CHD 
and CVD models were relatively similar (5,971 and 6,657 respectively); however, the AIC of the CHF model 
(1,943) indicates its comparatively high parsimony, which implicates the CHF model for having the best predic-
tive utility amongst the three43.
It is critical here to discuss the salience of these NTRA parameter changes to physiological changes associated 
with muscle degeneration. We have previously hypothesized that the characteristic infiltration of fat into lean 
muscle tissue defined as myosteatosis would result in a shift of ‘pure’ fat or muscle CT pixels towards the center of 
Figure 4. Results from tissue-based machine learning feature importance. (A) Example of a segmented 
false-color CT cross-section to illustrate the morphology of fat (orange), loose connective (blue), and lean 
muscle (red) tissue. (B) Total model accuracy (%) for each algorithm and cardiac pathophysiology, visually 
illustrating (with analogous colors) the compositional accuracy of each model with respect to tissue type. (C) 
Compositional accuracy (%) for each model with respect to tissue type.
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the HU distribution due to radiodensitometric value averaging34. This could, in-turn, result in several distribu-
tional changes that may occur independently; decreases in fat and muscle amplitude, a shift in fat and muscle peak 
locations towards zero, an increase in connective amplitude and a decrease in its width, and increases in fat and 
muscle skewness magnitude. Here, we see all of these phenomena together in the logistic regression prediction 
of all three adverse cardiovascular outcomes, with the exception of skewness terms. Indeed, this offers a possible 
explanation for our aforementioned counterintuitive protective factors of increased fat amplitude and connective 
tissue width for all three conditions. Altogether, these results serve as strong evidence that NTRA parameters hold 
utility in linking subtle physiological indicators of myosteatosis with cardiovascular health. While this relation-
ship is strong for the classification of CVD and CHD, the prediction of CHF is particularly robust.
It is likewise important to discuss the pathophysiological characteristics of the three cardiovascular outcomes 
utilized in this study to interrogate the particular predictive strength of CHF and relative similarity in prediction 
of CVD and CHD. Firstly, CVD is understood as an overarching typology of cardiovascular conditions that 
includes CHD alongside a host of other disease types, such as atherosclerosis or myocardial infarction44. As such, 
the comparative prediction of all-type CVD and CHD may be expected to be relatively similar. Contrastingly, 
CVD and CHD have been implicated as a primary etiology of CHF alongside other key comorbidities such as 
diabetes45. As such, while CHF may be a downstream consequence of CVD or CHD, its prediction likely relies on 
additional exogenous factors and may therefore be relatively independent. This could explain the relative similar-

















GB 79.0 81.7 73.6 84.5 73.6 82.6 0.883
RF 87.5 90.2 83.7 91.3 83.7 90.5 0.953
ADA-B 84.3 89.3 79.5 89.2 79.5 88.0 0.920
76–83
GB 75.9 79.7 69.5 82.3 69.5 79.7 0.862
RF 85.3 87.4 82.9 87.7 82.9 87.1 0.930
ADA-B 77.0 82.3 71.0 83.0 71.0 80.7 0.836
84–98
GB 72.8 81.1 79.4 66.2 79.4 70.2 0.825
RF 82.0 86.2 86.3 77.7 86.3 79.4 0.908
ADA-B 71.3 81.0 81.0 61.7 81.0 61.7 0.769
CVD
66–75
GB 76.4 79.6 70.9 81.9 70.9 79.6 0.868
RF 85.4 88.0 81.7 89.1 81.7 88.2 0.937
ADA-B 78.3 82.1 73.6 83.1 73.6 81.3 0.858
76–83
GB 72.0 76.2 66.4 77.6 66.4 74.8 0.817
RF 80.6 82.4 78.5 81.9 78.5 82.7 0.890
ADA-B 66.1 73.2 61.1 71.2 61.1 68.0 0.725
84–98
GB 68.9 76.2 77.2 60.6 77.2 66.2 0.786
RF 78.0 88.9 83.7 72.4 83.7 75.2 0.875
ADA-B 62.9 67.6 64.3 61.5 64.3 62.5 0.659
CHF
66–75
GB 93.8 95.0 91.5 96.0 91.5 95.8 0.981
RF 97.9 99.2 97.5 98.4 97.5 98.4 0.998
ADA-B 97.5 98.7 96.2 98.8 96.2 98.8 0.997
76–83
GB 88.1 90.5 84.6 91.7 84.6 91.0 0.963
RF 96.0 97.0 94.7 97.4 94.7 97.3 0.995
ADA-B 94.2 96.4 92.2 96.1 92.2 95.9 0.986
84–98
GB 82.6 87.8 88.2 76.9 88.2 79.2 0.921
RF 92.6 96.4 92.8 92.4 92.8 92.4 0.981
ADA-B 89.9 93.5 92.5 87.2 92.5 87.9 0.964
Table 6. The 11 nonlinear trimodal regression analysis parameters were used to assess cardiovascular risks on 















GB 88.3 90.3 85.5 91.2 85.5 90.7 0.959
RF 95.5 97.0 93.7 97.3 93.7 97.2 0.993
ADA-B 94.3 95.8 96.2 92.3 92.3 96.0 0.986
Table 7. The 11 nonlinear trimodal regression analysis parameters from AGES-I were used to predict the 
presence of chronic heart failure in AGES-II through machine learning algorithms and evaluation metrics were 
computed.
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diagnostics and predicted probability curves (Appendix A) show striking similarities between CHD and CVD 
models which largely differ from CHF curves.
From our ML models, there were again similarities between the classification accuracy of CVD and CHD, 
while CHF classification consistently outperformed the other two conditions. Nevertheless, all three conditions 
yielded high overall accuracies and excellent AUCROC values, suggesting the high general utility of NTRA-based 
modelling for all outcomes. Regarding tissue-based feature importance (Table 4), several key insights are shown, 
with differences apparent between cardiovascular conditions. Firstly, fat had a predominate role in classifying 
CHD (41.0%), while muscle had a comparatively minor contribution (11.9%). Contrastingly, lean muscle gave the 
highest contribution in classifying CHF (41.0%), while connective tissue yielded the lowest contribution (24.9%). 
Finally, fat and connective tissue gave almost the same contribution in classifying CVD (about 33.2% and 31.3%, 
respectively), while lean muscle was comparatively much lower (17.6%). These condition-based differences in 
classification indicate the potential specificity of tissue types to each condition, further suggesting the importance 
of segmenting classifying parameters by these three tissue types, which is one of the key features of NTRA com-
putational modelling.
The value of the present work. In general, this work features several key novelties for the use of skeletal 
muscle to classify cardiovascular health in advanced age. Firstly, we describe the NTRA computational model-
ling method, wherein radiodensitometric distributions from CT image cross-sections yield 11 subject-specific 
soft-tissue parameters that altogether present a robust and standardizable construct for quantifying muscle 
degeneration. This method has shown sensitivity and specificity to lower-extremity function and nutritional 
parameters in previous investigations33,34, but the present use of these parameters to classify cardiovascular health 
outcomes is new. Furthermore, the present work utilizes these NTRA parameters to compare the classification 
accuracy of three tree-based ML model algorithms with standard multinomial logistic regression, which is again 
novel in the context of cardiovascular health. Finally, we validate the ML classification results using longitudinal 
CHF data to independently model the prediction of CHF incidence.
Altogether, a key advantage of this methodology is its derivation from CT images. As a non-invasive and 
standardized imaging modality that is widely utilized for diagnostic applications and pathophysiological moni-
toring, CT-derived HU distributions of soft-tissue radiodensity can be directly compared across clinical contexts. 
As such, the present use of NTRA-based classification is highly reproducible and can be readily built into existing 
CT analysis frameworks for patient evaluation. This tool can be further adapted into additional ML-based plat-
forms for the detection and monitoring of adverse health outcomes in accordance with the current paradigm 
shift towards personalized medicine46. Altogether, the present work serves as a substantial step forward in the 
construction of reproducible tools for associating skeletal muscle changes with cardiovascular health outcomes 
in elderly individuals.
Limitations. As the AGES-Reykjavik study consisted of otherwise-healthy volunteers (presenting with or 
without various pathologies), standard clinical measurements of key cardiac functions, such as coronary perfu-
sion or ejection fraction measurement, were absent from the dataset. For this reason, the primary purpose of this 
work to test the classification of cardiac health from NTRA parameters. However, the validity of our results would 
be strengthened by the classification of these intermediate clinical measurements, as the outcomes of CVD, CHD, 
and CHF are largely heterogeneous in nature. The future use of our reported methods with clinical cardiovas-
cular data would likewise allow for the interrogation of the causal relationship between cardiac health outcomes 
and changes in radiodensitometric NTRA values. Further testing of this relationship using independent patient 
cohorts may likewise be needed to further refine our ML models.
Although in the multinomial logistic regression there are graphical (Fig. 2) and statistical (Table 3) indica-
tions of sex differences between the NTRA distributions, particularly associated to muscle and fat amplitude, this 
research did not investigate deeply this theme. Thus, further studies could focus more on this direction.
Finally, while evidence for the classifying power of ML-modelling continues to grow, its literature base still 
lacks a standardized methodology, and the mechanisms governing some of these classifications may remain 
unclear. As such, exploring the contextual value of different ML-modelling algorithms remains essential.
Materials and Methods
The AGES-I and AGES-II database. The AGES-Reykjavík study recruited 3,316 healthy subjects from 
66–98 years of age (mean: 77.46) to participate in a series of two multimetric assessments separated by approx-
imately five years, collectively defined as the AGES-I and AGES-II database. Informed consent was obtained 
from all participants47, ethical approval for patient data acquisition was obtained by the Icelandic Science and 
Ethics Committee (RU Code of Ethics, cf. Paragraph 3 in Article 2 of the Higher Education Institution Act no. 
63/2006), and patients’ data were acquired in accordance with relevant international regulations of both Iceland 
and U.S. National Institutes of Health.In addition to receiving CT scans (see ‘CT acquisition’) and having a host 
of nutritional, neurological, and lifestyle parameters measured or surveyed, subjects were assessed for the inci-
dence of CVD, CHD, and CHF. Of the original recruitment, n = 3,157 subjects participated in both the AGES-I 
and AGES-II studies separated by five years; as new CT images and incidences of cardiovascular pathophysiology 
were obtained separately in both studies, the total dataset size for the present work contained 6,314 records.
CT acquisition and segmentation. All participants in the AGES-Reykjavík database were scanned with 
a 4-row CT detector system at 120-kV (Sensation; Siemens Medical Systems, Erlangen, Germany) as previously 
described34. The localized scanning region extended from the iliac crest to the knee joints; prior to transaxial 
imaging, correct positions were determined by measuring the maximum femoral length on an anterior-posterior 
localizer image, followed by the localization of the center of the femoral long axis. After image acquisition, for 
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each subject, a single 10 mm section was taken from mid-thigh, midway between the acetabulum of the hip joint 
and the knee joint. Pixels from this slice were then processed to obtain subject-specific distributions of radioden-
sitometric values across the range of −200 to 200 HU.
Nonlinear trimodal regression analysis (NTRA). The method utilized to computationally describe each 
HU distribution was a form of modified nonlinear regression analysis that has been previously described33. Here, 
each HU distribution is defined as a quasi-probability density function defined by three Gaussian distributions 
(two skewed and one standard):
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where N is the amplitude, μ is the location, σ is the width, and α is the skewness of each distribution – all of which 
are iteratively evaluated at each CT bin, x. This trimodal definition operationalizes the hypothesis that HU distri-
butions across segmented soft tissue represent the sum of three distinct tissue types whose linear attenuation coeffi-
cients primarily occupy specific HU domains: namely, fat [−200 to −10 HU], loose connective tissue and atrophic 
muscle with approximately water-equivalent absorptivity [−9 to 40 HU], and lean muscle [41 to 200 HU]. The 
inwardly-sloping asymmetries characterized by fat and muscle distributions can be described respectively by their 
positive and negative skewnesses, whereas the central ‘connective’ tissue distribution is assumed to be non-skewed. 
Utilizing this definition, theoretical curves can be iteratively generated for each HU distribution by employing a 
generalized reduced gradient algorithm via the minimization of the sum of standard errors at each CT bin value. 
This method thereby generates 11 NTRA parameters that are altogether unique to every individual’s CT image.
Multinomial logistic regression models and statistical analyses. As a comparative and complimen-
tary analysis to ML modelling, three multivariate logistic regression models were first generated using generalized 
linear models employing the logit link function. Classification was defined for CHD, CVD, and CHF binary 
indicator variables, with each of the 11 NTRA parameters taken as independent predictors, with age and sex 
corrected for as hypothesized confounders; in total, 62 individuals were removed due to missing pathophysiology 
data. Predicted probabilities curves were then generated for each model, along with scatter plots for each NTRA 
predictor generated against the logit for each cardiovascular outcome to identify any nonlinearity in predic-
tor variables. Deviance residual diagnostic plots were likewise generated to assess model heteroscedasticity and 
identify any outliers with sufficient leverage, as defined by Cook’s distance. Next, log-odds coefficients for each 
NTRA parameter were exponentiated to enable the direct comparison of their contributory odds ratios for each 
cardiovascular pathophysiology, along with 95% confidence intervals and individual-level statistical significance. 
Finally, overall model significance was calculated by computing the differences in χ2 values between null and 
residual deviances; logistic regression classification accuracy for each model was later computed alongside ML 
models to facilitate comparison.
ML methodologies. After computing logistic regression models to predict CHD, CVD, and CHF, three 
tree-based ML model algorithms were performed as a methodological comparison of prediction accuracy using 
the 11 NTRA parameters: random forests (RF), ADA-Boost (ADA-B), and gradient boosting (GB). First, how-
ever, the ‘Smote’ technique for achieving dataset balance and k-fold cross-validation were utilized to ascertain the 
optimum number of mutually-exclusive folds for ML models to train and test. Following this, the results from 
each ML model were assembled over a typology of five comparisons: total classification score, classification by 
tissue type, tissue-based feature importance, classification by age, and finally classification with longitudinal data. 
Each of these analyses is described in the following sections.
Knime analytic platform. The Konstanz Information Miner (Knime) analytics platform (v. 3.7.1) was 
employed to conduct the ML model analyses in the present study48. In the Knime platform, ML analyses are 
managed through a comfortable and intuitive workflow by combining multiple nodes and facilitating the config-
uration of each parameters to optimize results. Knime was in the class of “leaders” identified by the Gartner Magic 
Quadrant in 2017, and its validity is widely acknowledged in literature49; for example, Ricciardi et al. employed 
it in a study regarding gait analysis on parkinsonian patients50, and Romeo et al. and Ricciardi et al. conducted 
a radiomics ML study using Knime51. Similarly to the analyses reported in our present work, Mannarino et al. 
adopted the Knime platform to perform a comparison between two SPECT imaging modalities in a cardiac study 
and a prediction on the follow up of patients suffering from coronary artery disease52–54.
Smote. Some supervised algorithms learning (such as decision trees) require an equal class distribution 
to obtain better and realistic classification performance. When required for the present ML methods, ‘Smote’ 
(Synthetic Minority Over-sampling Technique) was employed – a technique that implements an algorithm55 that 
generates artificial data by extrapolating between a real object of a given class and one of its nearest neighbors 
(of the same class). It then chooses a point along the line between these two objects and determines new object 
attributes based upon this randomly chosen point.
K-fold cross-validation. Finally, prior to ML modelling, the statistical procedure known as k-fold 
cross-validation was employed56; this method divides a dataset randomly into ‘k’ mutually-exclusive subsets (or 
‘folds’) of equal dimension. This model is then trained and tested ‘k’ times, wherein each training is performed 
on different ‘k–1’ folds and tested on fold ‘k’. The cross-validation estimate of accuracy is defined as the overall 
number of correct classifications divided by the number of instances in the dataset.
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Machine learning tree-based algorithms. The ensemble learning techniques of randomization, bagging 
and boosting were applied on decision tree. On the one hand, decision tree is the easiest algorithm known in liter-
ature and it does not need the normalization of the six thousand patients in AGES dataset; on the other hand, it is 
a weak and instable learner and ensemble techniques are useful to improve the performance of weak and instable 
algorithms and reduce the noise in AGES dataset.
The first ML method employed for this work was the Random Forests (RF) ensemble learning method, which 
features Decision Trees that share identical basic properties and the capacity to avoid overfitting57,58. Each tree is 
learned on its own, but some randomization is injected into this phase to reduce the variance of the predictions; 
this is performed by subsampling the AGES on each iteration to get a different training set or consider different 
random subsets of the 11 NTRA to split upon at each tree node. To make a prediction on a new patient, RF aggre-
gates predictions from all their decision trees by a majority vote.
The second ML method we utilized was Ada-Boost (ADA-B) – another ensemble method belonging to the 
boosting family, whose core principle is the strengthening of weak learners59. ADA-B training selects only the 
NTRA parameters that improve the predictive power of the model, reducing model complexity in terms of 
dimension and thereby improving execution time. Data modifications at each boosting iteration consist of apply-
ing weights to every training sample, setting them such that the first step consists of training the learner on the 
original training data. For all other successive iterations, sample weights are modified, and the learning algorithm 
is applied again to the data with its new weight. At a given step, patients used for training that were wrongly 
predicted by the boosted model at the previous step have their weights increased, whereas these weights are 
decreased for examples that were predicted correctly. As iterations proceed, patients that are difficult to predict/
diagnose receive ever-increasing influence. Each sequential weak learner is then forced to concentrate on patients 
that are previously missed.
The third ML method utilized for the present work was Gradient Boosting (GB); this method produces com-
petitive, highly robust, interpretable procedures for both classification and regression, which is especially appro-
priate for mining sub-optimally clean data. Our implementation follows the algorithm of Friedman60. Not only 
does this method exploit randomization and bagging principles, but it also includes a special form of boosting to 
build an ensemble of weak models (in this case, decision trees).
Evaluation metrics. A wide range of evaluation metrics are well known in literature61, but the following six 
were employed for this study:
•	 Accuracy: the number of correct predictions over their total number.
•	 Recall: the fraction of positive patterns that are correctly classified.
•	 Precision: the positive patterns correctly predicted over the total number of predictions in a positive class.
•	 Sensitivity: the number of true positives over the sum of true positives and false negatives.
•	 Specificity: the number of true negatives over the sum of true negatives and false positives.
•	 AUCROC: Area Under the Curve Receiver Operating Characteristic – probabilistic performance measure-
ment of classification.
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